PMC - Pharmerica Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
0.00 (0.00%)
At close: 7:00PM EST
Stock chart is not supported by your current browser
Previous Close0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
Press Releases
  • Business Wire8 months ago

    KKR Completes Acquisition of PharMerica

    PharMerica Corporation today announced the completion of the acquisition of PharMerica by a newly formed company controlled by KKR with an affiliate of Walgreens Boots Alliance, Inc.

  • Business Wire9 months ago

    PharMerica Reports Third Quarter 2017 Results

    PharMerica Corporation , a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the third quarter ended September 30, 2017.

  • Business Wire9 months ago

    PharMerica Announces Approval of Merger by Stockholders

    PharMerica Corporation , announced that at its special meeting of stockholders held today, a majority of the outstanding shares of PharMerica common stock voted to approve the adoption of the previously disclosed definitive merger agreement pursuant to which a newly formed company controlled by KKR, with Walgreens Boots Alliance, Inc.

  • Business Wire10 months ago

    Onco360 Selected for VERZENIO® Limited Distribution Pharmacy Network

    Onco360, the nation’s largest independent Oncology Pharmacy, announced today that it has been selected to participate in the limited distribution network for Eli Lilly and Company’s new product, VERZENIOTM , a twice daily oral cyclin-dependent kinase 4/6 inhibitor approved by the U.S.

  • PR Newswire10 months ago

    Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against PharMerica Corporation

    NEW YORK, Oct. 3, 2017 /PRNewswire/ -- Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the District of Delaware, case No. 1:17-cv-01301, on behalf of shareholders of PharMerica Corporation ("PharMerica" or the "Company") (PMC) who have been harmed by PharMerica's and its board of directors' (the "Board") alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") in connection with  the proposed merger of the Company with affiliates of Kohlberg Kravis Roberts & Co. L.P. ("KKR").

  • PR Newswire11 months ago

    SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PharMerica Corporation -- PMC

    NEW YORK , Sept. 7, 2017 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York ...